Allergy Therapeutics has announced the results of clinical trials that tested out a hay fever vaccine and found the results to be promising.
The study to test out the vaccine involved over 1,000 patients n the U.S., Canada and Europe. Overall there was a 13 to 27 percent improvement in the patients using the vaccine as compared to a placebo."Proof of efficacy and safety of Pollinex Quattro in this grass study is a breakthrough for allergy sufferers," said lead researcher Professor Tony Frew, Professor of Allergy and Respiratory Medicine at the Brighton and Sussex Medical School. "Patients showed significant and clinically meaningful improvement."
The Pollinex Quattro injection is given four times in three weeks before the pollen season starts.
Source-Medindia
RAS/M
